THPO and liver disorder: The mechanism underlying the reduced PLT counts in patients with severe fibrosis has been attributed to various processes, such as reduced hepatic production of thrombopoietin, increased splenic sequestration and destruction of PLTs in the enlarged spleen secondary to the myelosuppressive action of HCV, or portal hypertension [19, 20].